| Ονομασία του προϊόντος |
Rifalazil |
| Αγγλικό όνομα |
Rifalazil;KRM 1648; 3'-Hydroxy-5'-(4-isobutylpiperazinyl)benzoxazinorifamycin; 5,12-Dihydroxy-2,4-dimethyl-10-[4-(2-methyl-propyl)-l-piperazinyl]-2,7-[oxy(5-acetoxy-7,9-dihydroxy-3-methoxy-4,6,8,10,14-pentamethyl-15-oxo-l,ll,13-pentadecatriene-l,15-diyl)imino]-6H-benzofuro[4,5-a]phenoxazine-l(2H),6-dione; (2S,16Z,18E,20S,21S,22R,23R,24S,25S,26S,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-(2-methylpropyl)piperazin-1-yl]-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl acetate; (2S,16Z,18E,20S,21S,22R,23S,24S,25S,26S,27S,28E)-5,12,21,23-tetrahydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-10-[4-(2-methylpropyl)piperazin-1-yl]-1,6,15-trioxo-1,2-dihydro-6H,13H-2,7-(epoxypentadeca[1,11,13]trienoazeno)[1]benzofuro[4,5-a]phenoxazin-25-yl acetate |
| MF |
C51H64N4O13 |
| Μοριακό βάρος |
941.0729 |
| InChI |
InChI=1/C51H64N4O13/c1-24(2)23-54-16-18-55(19-17-54)32-21-33(57)39-35(22-32)67-48-40(52-39)36-37-44(60)30(8)47-38(36)49(62)51(10,68-47)65-20-15-34(64-11)27(5)46(66-31(9)56)29(7)43(59)28(6)42(58)25(3)13-12-14-26(4)50(63)53-41(48)45(37)61/h12-15,20-22,24-25,27-29,34,42-43,46,52,57-60H,16-19,23H2,1-11H3/b13-12+,20-15+,26-14-,53-41+/t25-,27-,28+,29-,34-,42-,43-,46+,51-/m0/s1 |
| CAS ΟΧΙ |
129791-92-0 |
| Μοριακή δομή |
|
| Πυκνότητα |
1.367g/cm3 |
| Σημείο βρασμού |
1048.573°C at 760 mmHg |
| Δείκτης διάθλασης |
1.634 |
| Σημείο ανάφλεξης |
587.956°C |
| Πίεση ατμών |
0mmHg at 25°C |
| Σύμβολα επικινδυνότητας |
|
| Κινδύνου Κώδικες |
|
| Περιγραφή της ασφάλειας |
|
|
